Nissay Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-6,182
Closed -$779K – 765
2024
Q2
$779K Buy
6,182
+139
+2% +$21.8K 0.01% 670
2024
Q1
$1.11M Buy
6,043
+100
+2% +$19K 0.01% 630
2023
Q4
$1.07M Buy
5,943
+226
+4% +$35.2K 0.01% 614
2023
Q3
$909K Buy
5,717
+198
+4% +$32.4K 0.01% 626
2023
Q2
$781K Sell
5,519
-92
-2% -$14.8K 0.01% 659
2023
Q1
$945K Sell
5,611
-206
-4% -$36.8K 0.01% 618
2022
Q4
$985K Buy
+5,817
New +$1.06M 0.01% 596

Other funds holding RGEN

Nissay Asset Management's RGEN Position: Q3 2024 in Review

Nissay Asset Management sold out of Repligen (RGEN) in Q3 2024, closing a stake of 6,182 shares — an estimated $779K sold.

Nissay Asset Management first reported a position in RGEN in Q4 2022 and held it in 7 quarters. The position peaked at $1.11M in Q1 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • Nissay Asset Management reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • Nissay Asset Management sold 6,182 Repligen shares in Q3 2024, an estimated $779K.
  • Nissay Asset Management first reported a position in Repligen in Q4 2022 and held it in 7 quarters.
  • Nissay Asset Management's Repligen position peaked at $1.11M in Q1 2024.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on Nissay Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.